Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. taviguide

TAVIguide

ICT platform to reduce mortality rates for Transcatheter Aortic Valve Implantation (TAVI) by pre-operative risk management

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 TAVIguide project word cloud

Explore the words cloud of the TAVIguide project. It provides you a very rough idea of what is the project "TAVIguide" about.

simulation    reducing    accurate    surgeons    mitral    patients    distinctly    thereby    disruptive    blood    12    3d    grow    thanks    complications    ict    validation    proposition    taviguide    size    disease    fast    tavi    additional    service    care    heart    approval    6    our    trade    aortic    mortality    centres    medical    4x    selling    fee    digital    society    mitigate    business    vii    share    4b    marketing    provides    revenue    therapy    lt    prospective    sustainable    manufacturers    entry    correctly    market    tackle    enabled    competitive    healthcare    positive    rates    quality    optimize    population    beneficial    pillar    groundbreaking    procedure    benefits    2021    software    fda    25    solution    2025    model    analysed    2014    license    elaborated    found    ageing    economic    give    implantation    commercialization    platform    patient    groups    prepare    huge    7b    offers    health    physicians    5    plan    preparation    innovative    offerings    verified    plus    valve    global    stakeholders    feasibility    flow    risk    device    operative    personalized   

Project "TAVIguide" data sheet

The following table provides information about the project.

Coordinator		 FEOPS NV 

Organization address
address: TECHNOLOGIEPARK ZWIJNAARDE 122
city: GENT
postcode: 9052
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Belgium [BE]
 Project website http://www.feops.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FEOPS NV BE (GENT) coordinator 50˙000.00

Map

 Project objective

Our market disruptive TAVIguide™ ICT solution (a Software-as-a-Service platform) will be distinctly beneficial for the global healthcare system with a positive impact on two main groups: a favourable economic impact for medical centres and physicians and an improved quality of care and experience for patients. Our ICT platform addresses an innovative digital health ICT concept and service and will help to tackle the society's challenge of growing needs for sustainable and personalized healthcare (ICT Pillar VII “ICT-enabled benefits for EU society”). It provides surgeons with a groundbreaking ICT solution thanks to beyond State-of-the-Art patient-specific 3D heart modelling and blood flow simulation for pre-operative analysis and preparation of aortic valve implantation. These unique features, not found in competitive offerings, allow to correctly assess and mitigate the complications risk, thereby reducing mortality rates across all TAVI patients from up to 25% after 1 year to <5%. Our TAVIguide™ platform offers a huge potential to device manufacturers who can use the accurate modelling and simulation features to further optimize their TAVI devices and prepare the way for patient-specific valve design. Our business concept is based on a software license revenue model plus fee per case. FDA approval and validation in a prospective patient study during Phase 2 will give us a unique selling proposition for different TAVI stakeholders. Commercialization of TAVIguide™ is planned on a global scale (EU and US). Due to the growing medical importance of the TAVI procedure and an ageing population, the target TAVI market is expected to grow from 1.4B€ (2014) to 4.7B€ (2025). We aim for a 12.6% share by 2021. An additional market entry for mitral valve disease therapy, 4x the TAVI market size, will be analysed. The elaborated business plan and verified technical and marketing feasibility for additional medical applications will prepare our solution for fast market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TAVIGUIDE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TAVIGUIDE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

DIGISTONE P1 (2014)

Production and Market entry financing of Digital Concrete Screen for Outdoor Digital Signage application

Read More  

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

WIMUACT (2017)

TECHNOLOGY FOR THE IMPROVEMENT OF SPORTS PERFORMANCE IN NON-PROFESSIONAL CONTEXTS

Read More